Login to Your Account

ConjuChem's Stock Falls On Plans To Delay Diabetes Drug

By Jennifer Boggs

Monday, October 3, 2005
Shares of ConjuChem Inc. plunged more than 50 percent after the company said it was temporarily stopping development of its DAC:GLP-1 compound in favor of a preclinical candidate that promises longer-term dosing to stabilize glucose levels in Type II diabetics. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription